BioSig Technologies, Inc. (BSGM)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Anthony Amato | CEO & Chairman | 257.88k | -- | 1968 |
| Mr. Ferdinand Groenewald | Interim CFO & Principal Accounting Officer | 106.5k | -- | 1985 |
| Dr. Budimir S. Drakulic Ph.D. | Chief Scientist | 169.64k | -- | 1950 |
| Ms. Lora Mikolaitis | Chief Administrative Officer | 96k | -- | 1973 |
BioSig Technologies, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
Description
BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Corporate Governance
Upcoming Events
May 19, 2025 at 8:00 PM UTC - May 23, 2025 at 8:00 PM UTC
BioSig Technologies, Inc. Earnings Date